Dedicating our resources to YOUR Cell Therapy Products & Exosomes

More than a classical…

C D M O A
Analytics-driven
Associate
Accelerator

 

Qualify your Product before patient injection

 

      • Cellfeature: Therapeutic performance
      • Cellnature: Identity
      • Cellsecure: Safety

Multi-expertise customized approach

 

      • From Donor tissue to Patients’ injection
      • Regulatory full support
      • Industrialization-focused strategies

Ready to use dedicated Platforms

 

 

Bridging the gap between R&D Project and clinical Development

Our Offer at a glance

From Regenerative Medicine to Immuno-Oncology,

From Autologous strategy to Allogeneic approach,

From primary cells to GMO cells

From Manufacturing Process, Analytics Bioassays, Quality Control Testing to Stability studies,

 

 

YOUR REQUIREMENTS ARE OUR PRIORITIES

 

 

 

YOUR Development stages

iPS Cells
Adult Stem Cells
EV & Exoxomes
Engineered Cells (CAR-T, CAR-NK,…)
Other ATMPs
Discovery
Pre-Clinical Development
Clinical Development
NDA Review & Approval
  • Ph.I
  • Ph.II
  • Ph.III
Post-Market monitoring
  • Ph.IV

OUR Offer

Regulatory coaching
Supply chain & human tissues sourcing
Process & analytical development
Process & analytical validation
Technical Transfer
R&D manufacturing
cGMP manufacturing
QC release & stability studies

Our partners

THEY TRUST US !

News

Press

28.02.2022

The OPTI-STEM consortium led by Cell-Easy to democratize access to cell therapy in France and Europe

Toulouse, La Madeleine, Nancy, France – 28 February, 2022 The […]

Read More

Press

07.02.2022

Virginie Duel joins Cell-Easy as Head of Quality Control.

The Cell-Easy management team is very pleased to announce the […]

Read More
View all

Contact

  • Tel : +33 534 276 550
  • Address : Cell-Easy SAS, 4 bis avenue Hubert Curien, 31100 Toulouse, France
  • Mail : info@cell-easy.com
European leading CDMO company specialized in large volume industrialized production of GMP approved cell products